Navigation Links
Dr. David Okrongly Appointed CEO of Quanterix Corporation
Date:9/2/2009

active participation and contributions to Quanterix's success."

Commenting on his new appointment, Dr. Okrongly said, "I am very excited to be joining a ground-breaking organization like Quanterix. A technology that enables unparalleled increases in analytical sensitivity will have significant applications in the diagnostics industry, allowing a variety of unmet medical needs to be addressed. I look forward to working with the current leadership team, employees and Board members as we continue to realize the full potential of this promising technology."

About Quanterix

Quanterix is developing a revolutionary Single Molecule Array (SiMoA(TM)) technology that allows the behavior of thousands of individual molecules to be observed simultaneously, rather than an ensemble average of many molecules as with existing technologies. Quanterix's platform will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. The first application that Quanterix is pursuing with the SiMoA(TM) technology is the detection and quantification of proteins present in blood and other body fluids at very low, previously undetectable, concentrations. Diagnostic assays targeting proteins that have been implicated in a variety of human diseases, including cancer, chronic inflammatory disease and neurological disorders are under development. Quanterix is a privately held company located in Cambridge, Massachusetts and is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures. For additional information, please visit www.quanterix.com.


'/>"/>
SOURCE Quanterix Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
3. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
4. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
5. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
6. St. Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders
7. David Grimes, FHI physician, inducted into Institute of Medicine
8. David Kahal Joins AXA Equitable as National Sales Manager
9. Leading Authority on Health Benefits, David Hom, Joins Board of Directors of Healthcare Technology Innovator, NavigatorMD, Inc.
10. Tree named in honor of Virginia Tech chemist David G.I. Kingston
11. David Luci Joins MacroChem as General Counsel and Vice President Corporate Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces that ... to better serve the needs of couples in Chicagoland. ... the Northwest side of the city at 4920 North Central ... calling the Chicago office at (773) 794–1818. This is ... Chicago. The other 2 offices are in Gurnee and ...
(Date:5/26/2015)... Missouri (PRWEB) May 27, 2015 ... recently filed testosterone gel lawsuit . The suit ... AbbVie. The suit was filed in late April 2015, ... filed in an Illinois federal court in mid-May.¹ , ... District Court for the Northern District of Illinois. The ...
(Date:5/26/2015)... May 27, 2015 Securityhunter ... (MATOC) by the United States Department of Health and ... The MATOC was awarded through the General ... (FSS) for the PSC, which is a fee-for-service agency. ... one year options, and is an enterprise–wide physical security ...
(Date:5/26/2015)... 26, 2015 Forex Income Boss is ... improving their results trading in the foreign exchange market. ... Horn, utilizes 10 customer indicators to help traders locate ... "As usual, Russ Horn's latest trading system is the ... community," reports Tiffany Hendricks, senior product reviewer at HonestyFirstReview.com. ...
(Date:5/26/2015)... Beloved local Arizona company, Parker and Sons, outdoes itself again ... or else its free. , Parker and Sons offers ... . What’s more, Parker and Sons offers a customer satisfaction ... rich legacy, and immense success. , The sixty minutes ... Whether it be low water flow or complete clogging, then ...
Breaking Medicine News(10 mins):Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Forex Income Boss - Review Of Russ Horn's New FX Trading System Released 2Health News:Parker and Sons Offers Special, Sixty Minute Drain Clean Guarantee or Else It’s on Them 2
... come with other NSAID pain relievers, experts say , , MONDAY, ... pulled from the market in 2004 -- over concerns that it ... assumed that stopping the drug would end the risk. , ... to twofold, and the risk persisted for approximately a year," said ...
... follow-up counseling for longer than one month significantly ... analysis of clinical trials of programs offered at ... long-term support can increase participant,s chances of success ... Nancy Rigotti, MD, director of the Tobacco Research ...
... suggests that the combination of low plasma levels of antioxidants ... certain forms of the eye disease age-related macular degeneration (AMD), ... Archives of Ophthalmology , one of the JAMA/Archives ... of light," the authors write as background information in the ...
... to cardiac rehabilitation, appear to be associated with increased ... a report in the Oct. 13, 2008, issue of ... JAMA/Archives journals. , Emory University researchers studied 639 patients ... heart attack. Six months later, 297 of the patients ...
... ,can,t remember anything, study says , , MONDAY, Oct. 13 ... than help guide your daily sleep/wake cycle -- it ... memory, say Stanford University researchers. , In tests with ... critical to the rodents, ability to memorize what they,ve ...
... Chargers Points to Myo-Med for Injury Recovery, PLEASANT ... points to Myo-Med ( http://www.myomed.com ) as,a key to ... Patriots,Tomlinson became the 17th player in NFL history to ... Sunday, a feat unexpected by critics who,thought his early ...
Cached Medicine News:Health News:Vioxx's Heart Risk Lingered Long After Use Ended 2Health News:Vioxx's Heart Risk Lingered Long After Use Ended 3Health News:Intensive support programs can help hospitalized smokers stay smoke-free 2Health News:Sunlight exposure plus low antioxidant levels may place older adults at risk for eye disease 2Health News:Circadian Rhythm Plays Role in Memory 2Health News:Tomlinson Attributes Rebound to Anti-Inflammatory Cream 2
(Date:5/26/2015)... DIEGO , May 26, 2015 ... developing targeted therapeutic devices to address infectious diseases ... Joyce , Chief Executive Officer, will present at ... Thursday, May 28th.  Details of Aethlon Medical,s presentation ... Investor Conference Date: , Thursday, May 28, 2015Time: ...
(Date:5/26/2015)... , May 26, 2015 ViiV ... Inc. (CHAI) announced today that Aurobindo Pharma has submitted ... for Tentative Approval, to the Food and Drug Administration ... first ANDA for a generic version of dolutegravir, less ... for sale in the United States ...
(Date:5/26/2015)... Mass. , May 26, 2015  Respiratory ... 62 nd Annual Meeting of the Japanese ... of monitoring patient respiration in hospitals miss critical ... risks to patients. The findings conclude that respiratory ... Respiratory Motion, Inc. more consistently protects patients than ...
Breaking Medicine Technology:Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... 2010 HeartWare International, Inc. (Nasdaq: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to make an investor presentation at ... December 7, 2010 at 9:00 a.m. Pacific Time (noon, ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced ... the UK has completed review of the Clinical Trial Application ... 673 for genetically-defined cancers.  The company expects to initiate a ... "BMN 673 has been proven to be highly active ...
Cached Medicine Technology:HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: